Saudi Arabia Pharmaceutical Market Analysis Research Report Till 2026: Novartis AG, SPIMACO, Pfizer Inc., and Glaxosmithkline Plc., Jamjoom Pharma
The significant rise in lifestyle-related diseases and the developments in healthcare infrastructure are expected to influence the demand for pharmaceuticals in Saudi Arabia. In 2016, the Saudi Arabia pharmaceutical market is anticipated to procure value worth US$ 5,209.5 Mn at a y-o-y growth of 6.0 % over 2015. The mounting demand for branded drug products will continue to incite the growth of the Saudi Arabian pharmaceutical market in 2016.
View full press release